Share:
Newark, NJ, May 24, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the
global antiviral drugs market is expected to grow from USD 44.01 Billion in 2020 and to reach USD 51.67 Billion by 2028, growing at a CAGR of 2.0% during the forecast period 2021-2028.
The factors driving the market are growing surge in healthcare framework payout ability, the extent of a well-established supply chain, increasing interest to brace the evolution of novel antiviral drugs, advances in the formulation such as fixed-dose combination and soaring requirement of diseases specific treatment, arise in public awareness, improvement in the R&D segment, increase in virus infections such as influenza, respiratory syncytial virus, hepatitis, HIV swine flu, Ebola, Zika virus and coronavirus. The factors restraining the market growth are awareness about the accessibility of vaccines for several diseases, growing precautionary measures, rising need for different medicines like naturopathy and homeopathy, reducing the cost of therapy, high cost involved in the development of drugs, high price of research, treatment and strict government activities.